DDL logo
Menu
  • The Aerosol Society logo
DDL logo
  • DDL2026
    • Delegate Registration
    • Programme Preview
    • The DDL Incubator
    • Attending Exhibitors and Sponsors
    • Exhibition & Sponsorship Opportunities
    • New Researcher Network
    • Hotel and Travel
    • Call for Papers
    • Media Partners
    • Frequently Asked Questions
  • Archive
    • Conference Papers Archive
    • DDL2025
      • Lecture Recordings
      • Conference Papers
      • Lecture Programme
      • EPAG Workshop
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2024
      • Lecture Recordings
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2023
      • Lecture Recordings
      • The Association of Inhalation Toxicologists – Workshop
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2022
      • Lecture Recordings
      • Academy of Pharmaceutical Sciences – Workshop
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2021
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Sponsors
    • Previous Years Conferences
  • DDL Annual Lecture
  • Awards & Grants
    • DDL Career Development Grant
    • The DDL Emerging Scientist Award
    • The Pat Burnell Young Investigator Award
    • Aerosol Society Awards
  • About
    • Gallery
    • History
    • DDL Charter
    • Committee
    • The Scientific Advisors
    • Contact
  • Associated Events
    • Annual Aerosol Science Conference
    • RDD 2027
  • The Aerosol Society logo
Sharareh Salar-Behzadi

Sharareh Salar-Behzadi

Research Center Pharmaceutical Engineering (RCPE) GmbH

Paper: Novel Inhalable Formulations for Targeted Delivery of Antibiotics to the Lung: A Response to the Global Tuberculosis Commitment

Download Paper

Sharareh Salar-Behzadi is key researcher at Research Center Pharmaceutical Engineering (RCPE) GmbH (http://www.rcpe.at/), Graz and Assoc. Professor at the department of pharmaceutical technology and biopharmacy, University of Graz, Austria. She studied pharmacy and received her PhD from University of Vienna in pharmaceutical formulation and process development. She was then a post doctoral fellow at the same university for 6 years. She joined RCPE GmbH in 2011 and the University of Graz as lecturer in 2014, and later as Assoc. Professor in 2020.
Her interest is in pharmaceutical material science, solid state, structure-function analysis of pharmaceutical excipients, with a focus on lipid-based drug delivery systems, particle engineering for different routes of administration, among them delivery to the lung, and patient-centric product development.
Salar-Behzadi has worked with a large number of pharmaceutical, excipient, and equipment companies and received significant funding for her work in lipid-based drug delivery systems. Her publication record encompasses over 60 peer-reviewed publications and 5 patents in this field.

  • Terms
  • Privacy & Cookie policy
  • Contact
  • Committee

© 2026 Drug Delivery to the Lungs Website design: definingdesign.co.uk